AIDS

1. YUAN R, Yan Y, Deng L, Li F, et al
   Risk factors of metabolic dysfunction-associated fatty liver disease in people living with HIV receiving antiretroviral therapy.
   AIDS. 2025 Nov 28. doi: 10.1097/QAD.0000000000004419.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

2. WANG H, Fan H, Guo C, Zhang X, et al
   Exploring Potential Associations Between HIV Acquisition and Biological Aging: Insights from a Bidirectional Mendelian Randomization Study.
   AIDS Res Hum Retroviruses. 2025 Nov 20. doi: 10.1177/08892229251399094.
   

   >> Share

   
   

   
   Am J Epidemiol

3. BARRINGTON WE, Kumar R, Frivold C, Massey AE, et al
   Racial affinity caucuses as anti-racist pedagogy in an epidemiology course.
   Am J Epidemiol. 2025;194:3572-3580.
   

   >> Share

   
   

   
   BMC Pediatr

4. KHOZA-SHANGASE K, Mnyaka N
   The impact of prematurity and neonatal complications on hearing function in children born to HIV-Positive mothers: A secondary data analysis in the South African context.
   BMC Pediatr. 2025;25:975.
   

   >> Share

   
   

   
   BMJ

5. WISE J
   HIV action plan: At-home tests to be trialled through the NHS app.
   BMJ. 2025;391:r2530.
   

   >> Share

   
   

   
   Br J Dermatol

6. VAN ROOIJ N, Sparkes A
   Biologic and Small-Molecule Therapies for Chronic Plaque Psoriasis in People Living with HIV: Current Evidence and Clinical Practical Considerations.
   Br J Dermatol. 2025 Dec 1:ljaf493. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

7. STEPHAN C, Albuquerque B, Schreiber S
   Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNE
   HIV Med. 2025 Dec 1. doi: 10.1111/hiv.70159.
   

   >> Share

   
   
8. RACCAGNI AR, Passini F, Lolatto R, Capra N, et al
   User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from Milan.
   HIV Med. 2025 Dec 1. doi: 10.1111/hiv.70162.
   

   >> Share

   
   
9. COUKAN F, Ogaz D, Saunders J, Murphy G, et al
   HIV PrEP use and unmet need among gay, bisexual and other men who have sex with men in London: An analysis of community cross-sectional surveys in England 2019-2022.
   HIV Med. 2025 Nov 30. doi: 10.1111/hiv.70157.
   

   >> Share

   
   
10. SURIAL B, Alagaratnam J
    HIV and cancer: Bridging two fields in transformation.
    HIV Med. 2025;26:1906-1908.
    

    >> Share

    
    
11. ZHANG H, Xia H, Shi F, Li Q, et al
    Sex differences in cardiovascular disease and associated factors in people living with HIV: Evidence from All of Us program.
    HIV Med. 2025 Nov 30. doi: 10.1111/hiv.70155.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

12. TIEN D, Chandiwana N, Shazi G, Chen G, et al
    Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa.
    J Acquir Immune Defic Syndr. 2025 Dec 2. doi: 10.1097/QAI.0000000000003812.
    

    >> Share

    
    
13. D'ANGELO AB, Patel VV, Carrico AW, Grov C, et al
    To err is human, to persist is diabolical: Are we repeating the same cost and insurance coverage mistakes again with injectable PrEP?
    J Acquir Immune Defic Syndr. 2025 Dec 2. doi: 10.1097/QAI.0000000000003817.
    

    >> Share

    
    
14. RASKOPF W, Mbewe E, Adams H, Buda A, et al
    a. Nutritional Status and Cognitive Function in Children with or exposed to HIV: Evidence from the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.
    J Acquir Immune Defic Syndr. 2025 Dec 2. doi: 10.1097/QAI.0000000000003811.
    

    >> Share

    
    
15. MPOFU R, Chandiwana N, Sokhela S, Moorhouse M, et al
    The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in Participants with HIV-associated Tuberculosis.
    J Acquir Immune Defic Syndr. 2025 Dec 2. doi: 10.1097/QAI.0000000000003810.
    

    >> Share

    
    

    
    J Infect Dis

16. MAKAROVA N, Singletary T, Peet MM, Kelley K, et al
    Partial post-exposure protection by topical inserts containing tenofovir alafenamide fumarate/elvitegravir in a macaque model of rectal SHIV infection.
    J Infect Dis. 2025 Dec 4:jiaf611. doi: 10.1093.
    

    >> Share

    
    
17. BUNJUN R, Lurie M, Dabee S, Barnabas S, et al
    Chlamydia trachomatis-specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young Women.
    J Infect Dis. 2025 Dec 3:jiaf595. doi: 10.1093.
    

    >> Share

    
    
18. TEWARI SE, Hoffman R, Lockman S, Flanagan CF, et al
    Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.
    J Infect Dis. 2025 Dec 1:jiaf521. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

19. DENG Z, Zhang X, Zhu A, Yang X, et al
    Subset Remodeling of MAIT and NK Cells Correlates With Immune Reconstitution in People Living With HIV Following Four Years of Antiretroviral Therapy.
    J Med Virol. 2025;97:e70732.
    

    >> Share

    
    
20. KARMOCHKINE M, Mariaggi AA, Leducq V, L'Honneur AS, et al
    KSHV Acquired During Chemsex With Resultant Multicentric Castleman's Disease in a Patient Successfully Treated for HIV.
    J Med Virol. 2025;97:e70749.
    

    >> Share

    
    
21. AFSARI B, Ramaswami R, Lurain K, Tagawa T, et al
    Spatial Transcriptomics of Patients With Kaposi Sarcoma Identifies Mechanisms of Immune Evasion.
    J Med Virol. 2025;97:e70728.
    

    >> Share

    
    

    
    J Virol

22. WANG Y, Fu S, Wang X, Gao G, et al
    Phosphorylation of Shiftless by casein kinase 1 delta/epsilon is required for its antiviral activity.
    J Virol. 2025 Dec 2:e0186425. doi: 10.1128/jvi.01864.
    

    >> Share

    
    
23. BALDINO AM, Mumby MJ, Edgar CR, Olabode AS, et al
    Ancestral reconstruction supports that loss of Nef-mediated T cell modulation coincided with the emergence of pathogenic lentiviruses.
    J Virol. 2025 Dec 2:e0154825. doi: 10.1128/jvi.01548.
    

    >> Share

    
    
24. YANG T, Chen M, Zhou M, Deng X, et al
    The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation.
    J Virol. 2025 Dec 3:e0151825. doi: 10.1128/jvi.01518.
    

    >> Share

    
    

    
    JAMA

25. TU SS, Bonis T, Sinha MS, Slade DH, et al
    Combination-Only Approvals as a Barrier to Affordable HIV Care.
    JAMA. 2025 Dec 1. doi: 10.1001/jama.2025.21935.
    

    >> Share

    
    
26. PERSON AK, Kelley CF
    World AIDS Day-At a Crossroads.
    JAMA. 2025 Dec 1. doi: 10.1001/jama.2025.23506.
    

    >> Share

    
    

    
    Lancet

27. THORNTON J
    Fiji faces major HIV outbreak.
    Lancet. 2025 Nov 30:S0140-6736(25)02430-4. doi: 10.1016/S0140-6736(25)02430.
    

    >> Share

    
    

    
    N Engl J Med

28. RATEVOSIAN J, Beyrer C, Chola M, Huchko M, et al
    The New U.S. Global Health Strategy - A Reset of America's Health Cooperation.
    N Engl J Med. 2025;393:2180-2182.
    

    >> Share

    
    

    
    Nature

29. GOFF S
    David Baltimore obituary: virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS.
    Nature. 2025;648:31.
    

    >> Share

    
    
30. LI JZ
    Antibodies and T cells join forces for sustained HIV remission.
    Nature. 2025 Dec 1. doi: 10.1038/d41586-025-03805.
    

    >> Share

    
    
31. GAEBLER C, Kor S, Allers K, Perotti M, et al
    Sustained HIV-1 remission after heterozygous CCR5Delta32 stem cell transplantation.
    Nature. 2025 Dec 1. doi: 10.1038/s41586-025-09893.
    

    >> Share

    
    
32. KIANI Z, Urbach JM, Wisner H, Olatotse MJ, et al
    CD8(+) T cell stemness precedes post-intervention control of HIV viremia.
    Nature. 2025 Dec 1. doi: 10.1038/s41586-025-09932.
    

    >> Share

    
    
33. PELUSO MJ, Sandel DA, Deitchman AN, Kim SJ, et al
    Correlates of HIV-1 control after combination immunotherapy.
    Nature. 2025 Dec 1. doi: 10.1038/s41586-025-09929.
    

    >> Share

    
    

    
    PLoS Comput Biol

34. LONGLEY H, Fraser C, Wymant C, Lythgoe K, et al
    Attenuation of HIV severity by slightly deleterious mutations can explain the long-term trajectory of virulence evolution.
    PLoS Comput Biol. 2025;21:e1013131.
    

    >> Share

    
    

    
    PLoS Med

35. FAUCI AS, Folkers GK
    Treatment and prevention of HIV/AIDS: Unfinished business.
    PLoS Med. 2025;22:e1004806.
    

    >> Share

    
    

    
    PLoS One

36. NDLOVU NL, Scheibe A, Hausler H, Sonderup MW, et al
    Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016-2017.
    PLoS One. 2025;20:e0336614.
    

    >> Share

    
    

    
    PLoS Pathog

37. WALLIS ZK, Midkiff CC, Zhao M, Autissier P, et al
    Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS.
    PLoS Pathog. 2025;21:e1013180.
    

    >> Share

    
    
38. MULLER NF, Wick RR, Judd LM, Williamson DA, et al
    Quantifying plasmid movement in drug-resistant Shigella species using phylodynamic inference.
    PLoS Pathog. 2025;21:e1013621.
    

    >> Share

    
    
39. OLLERTON MT, Folkvord JM, Bush V, Parry DA, et al
    Lymphoid B cells upregulate HIV-1 ex vivo and are linked to its expression in vivo.
    PLoS Pathog. 2025;21:e1013661.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

40. NELSON JAD, Garfinkle SE, Lin ZJ, Park J, et al
    Machine learning enables de novo multiepitope design of Plasmodium falciparum circumsporozoite protein to target trimeric L9 antibody.
    Proc Natl Acad Sci U S A. 2025;122:e2512358122.
    

    >> Share

    
    

    
    Vaccine

41. HAMMOUD M, Smith AKJ, Sachs O, Bavinton BR, et al
    Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024).
    Vaccine. 2025;70:128041.
    

    >> Share

    
    
42. LE TOURNEAU N, Sharma A, Pry JM, Haambokoma M, et al
    Drivers of decision-making for future adult vaccines: a best-worst scaling among community members and health care workers in Zambia.
    Vaccine. 2025;70:128003.
    

    >> Share

    
    
43. FREY SE, Baden LR, El Sahly HM, Davey RT, et al
    Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.
    Vaccine. 2025;69:127959.
    

    >> Share

    
    

    
    Virology

44. MADURANGA S, Valencia BM, Sigera C, Weeratunga P, et al
    Between- and within-host mutation of dengue virus.
    Virology. 2025;615:110750.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share